Nuveen Asset Management
TLIS

Nuveen Asset Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-53,809
Closed -$82K 3442
2022
Q1
$82K Buy
53,809
+3,522
+7% +$5.37K ﹤0.01% 3253
2021
Q4
$186K Sell
50,287
-4,197
-8% -$15.5K ﹤0.01% 3240
2021
Q3
$392K Buy
54,484
+14,424
+36% +$104K ﹤0.01% 3214
2021
Q2
$442K Buy
40,060
+18,645
+87% +$206K ﹤0.01% 3179
2021
Q1
$275K Buy
+21,415
New +$275K ﹤0.01% 3188